NHI CIO granted 5,072 restricted shares

PASCOE KEVIN CARLTON reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/05/2026 - 04:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

PASCOE KEVIN CARLTON reported acquisition or exercise transactions in this Form 4 filing.

NATIONAL HEALTH INVESTORS INC reported an insider equity award for Chief Investment Officer Kevin Carlton Pascoe. On March 3, 2026 he received a grant of 5,072 shares of common stock as restricted stock, recorded at a per-share price of $0.0000.

According to the filing, this restricted stock grant vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to his continued service through each vesting date. After this award, he directly held 73,428 shares of common stock.

Insider Trade Summary

Grant/Award: 5,072 shares

Grant/Award 1 txn

Insider PASCOE KEVIN CARLTON

Role Chief Investment Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,072	$0.00	$0.00

Holdings After Transaction: Common Stock — 73,428 shares (Direct)

Holdings Before and After: Common Stock, 68,356 to 73,428 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHI report for Kevin Carlton Pascoe?

NATIONAL HEALTH INVESTORS INC reported a grant of restricted common stock to Chief Investment Officer Kevin Carlton Pascoe. He was awarded 5,072 shares on March 3, 2026, recorded at a price of $0.0000 per share, increasing his direct holdings to 73,428 shares.

How many NHI shares were granted to the CIO on March 3, 2026?

Kevin Carlton Pascoe received a grant of 5,072 shares of NATIONAL HEALTH INVESTORS INC common stock on March 3, 2026. The filing classifies this as a restricted stock award with a transaction price per share of $0.0000, reflecting a non-cash, equity-based compensation grant.

What is the vesting schedule for Kevin Carlton Pascoe’s NHI restricted stock?

The 5,072 restricted shares granted to Kevin Carlton Pascoe vest in three equal annual installments. Vesting begins on March 3, 2027, with additional vesting on each anniversary of the grant date, subject to his continued service through each vesting date as disclosed.

How many NHI shares does Kevin Carlton Pascoe hold after this grant?

Following the restricted stock grant, Kevin Carlton Pascoe directly holds 73,428 shares of NATIONAL HEALTH INVESTORS INC common stock. This total reflects his ownership immediately after the March 3, 2026 award of 5,072 restricted shares reported in the Form 4 filing.

Was the NHI restricted stock grant to the CIO a purchase or an award?

The transaction is classified as a grant or award acquisition, not an open-market purchase. The Form 4 lists transaction code “A” for an award of 5,072 restricted shares at a price of $0.0000 per share, representing equity compensation rather than a cash-funded share purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PASCOE KEVIN CARLTON

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		5,072(1)	A	$0	73,428	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.